Chronic Pancreatitis Pain Market - Forecast(2022 - 2027)

Report Code: HCR 0120 Report Format: PDF + Excel

Chronic Pancreatitis Pain Market Overview

The Chronic Pancreatitis Pain Market size is estimated to reach $11.8 billion by 2027. Furthermore, it is poised to grow at a CAGR of 5.2% over the forecast period of 2022-2027. Chronic pancreatitis is a serious condition that develops owing to the entrapment of digestive enzymes within the pancreatic ducts, instead of traveling to the upper intestine. Owing to such anomaly, it can cause inflammation resulting in pain and scarring. Further, short-term pancreatitis can cause malabsorption-thereby forcing people to start taking enzymes as the body is incapable of producing enzymes that would digest foods. Chronic Pancreatitis can also cause diabetes, as the body can’t make insulin which controls the body’s blood sugar. If acute pancreatitis doesn’t get better and slowly gets worse, one may have chronic pancreatitis. Lastly, a lot of diagnosis techniques are being developed. For example, magnetic resonance cholangiopancreatography is a test that uses radio waves- a strong magnet and a computer. It would allow for better detection of such conditions. The rise of lifestyle-related diseases such as hypertension and diabetes has been a driving force behind the growth of the Chronic Pancreatitis Pain Industry in the projected period of 2022-2027.

Chronic Pancreatitis Pain Market Report Coverage

The report: Chronic Pancreatitis Pain Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Flavored Bottled Water Market.

By Causes: Damaged Pancreatic Duct, Cancer, Auto-Immune Disorder, Cystic Fibrosis, Hereditary, And Others.
By Diagnosis: Blood Tests, Imaging Techniques, Endoscopy, and Others.
By Treatment: Lifestyle Management (Conservative Management), Endoscopy, and Surgical Interventions.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and Rest of World (the Middle East and Africa).

Key Takeaways

  • Geographically, North America’s chronic pancreatic pain market held a dominant market share in the year 2021. It is owing to the presence of robust medical infrastructure which facilitates easy medical claims and other cash-backs. Further, the prevalence of such pancreatic disease is significantly higher in western regions. However, Asia-Pacific is expected to offer lucrative growth opportunities over the forecast period of 2022-2027 owing to the high prevalence of diabetes and cancer which can lead to chronic pancreatic.
  • The rise of lifestyle-related diseases such as hypertension and diabetes has been a driving force behind the growth of the market. However, no line of treatment and high aiding cost has been impeding the market growth.
  • A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Chronic Pancreatitis Pain Market Report.

Chronic Pancreatitis Pain Market- Geography (%) for 2021.

Chronic Pancreatitis Pain Market

For more details on this report - Request for Sample

Chronic Pancreatitis Pain Market Segmentation Analysis- By Diagnosis

The chronic pancreatitis pain market based on diagnosis can be further segmented into Blood Tests, Imaging Techniques, Endoscopy, and Others. Blood Tests hold a dominant market share in the year 2021. Blood tests help in diagnosing two important pancreatic enzymes- amylase and lipase. The following may spill in one’s blood. Additionally, other blood tests can help in checking blockage or damage to the gallbladder. Additionally, certain inherited conditions can also be checked via blood tests. Studies have governed that after heavy alcohol consumption, decrease in the production of pancreatic isoamylase and salivary isoamylase. Russia for example consumes around 12 liters of pure alcohol each year.

Endoscopy is estimated to be the fastest-growing, with a CAGR of 6.5% over the forecast period of 2022-2027. Endoscopy is a non-surgical procedure that is used to examine a person’s digestive tract, which goes through one’s body and has a camera that allows the doctor to have a clearer image. ERCP goes through the pancreas drainage area if every treatment needs to be done. However, ERCP is a high-risk procedure and patients often are wary of the outcomes.

Chronic Pancreatitis Pain Market Segmentation Analysis- By Treatment

The chronic pancreatitis pain market based on treatment can be further segmented into Lifestyle Management (Conservative Management), Endoscopy, and Surgical Interventions. Lifestyle Management or Conservative Management holds a dominant market share in the year 2021. Cessation of smoking, pain medication, and dietary advice are some of the common factors or lines of treatment for most patients owing to the low cost of treatment and the doctor’s recommendation to follow certain regimens. Digestive enzymes are coming under the category and allow for an efficient process. Around INR 799 is required for 90 days, which would substantially round up to immense cost savings.

However, Surgical Interventions are estimated to be the fastest-growing, with a CAGR of 6.7% over the forecast period of 2022-2027. Surgical interventions have proven to be effective, in comparison with other lines of treatment proven if they are provided at the right time. In a trial conducted amongst 85 patients, during 18 months of follow-up, patients in the early surgery group had a lower Izbicki pain score than patients in the group randomized to receive the endoscopy-first approach group (37 vs 49; between-group difference, 12 points [95% CI, 22 to 2].

Chronic Pancreatitis Pain Market Segmentation Analysis- By Geography

The chronic pancreatitis pain market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the rest of the world. North America dominated with a market share of 37% in 2021. North America spends the highest in terms of healthcare infrastructural cost, and around $4 trillion for the healthcare budget has been allotted of around $22 trillion in 2021. Additionally, the cost of healthcare allocation has been growing around 1.1 times faster than the overall GDP. Additionally, the average incidence of chronic pancreatitis has been around 60.2 years, further the geriatric population has been growing at a stand-forward rate.

However, Asia-Pacific is expected to offer lucrative growth opportunities over the forecast period of 2022-2027. It is owing to the rising geriatric population supplemented by higher budget allocation and better infrastructural capabilities.

Chronic Pancreatitis Pain Market Drivers

The factors which lead to chronic pancreatitis have been a prime reason for the market growth.

Chronic pancreatitis has been a prevalent reason for the growing prevalence of chronic pancreatitis. As per various surveys, smoking has been attributed as one of the primary reasons for developing such pain and condition. A strong association has been found between gallstones as a potential mediator between smoking and pancreatitis. Additionally, the study provided rolled out how participants at baseline who reported smoking or being previous smoking history had a higher risk of developing the condition than those who haven’t had exposure. Along with the study, it was also found that 62% of the current smokers were enlisted in the study, of which 46% of cases of pancreatitis were solely attributed to smoking. In 2020, more than 4.5 million US youth were seen or recorded smoking e-cigarettes. Additionally, states of the US are not proactive in reducing the overall load by smoking prevention norms. In the fiscal year 2020, around $27.2 billion was collected by states through taxes and court settlements, of which around $740 million was spent on prevention measures. However, CDC recommends that around 12% of 3.3 billion USD be spent on such activities. Owing to such leniency, the overall market is positioned favorably.

The growing number of pancreatic cancer patients is readily attributed to the growing cases of chronic pancreatitis.

Chronic pancreatitis has been shown to increase the risk of pancreatic cancer. After five years of diagnosis of the former, the chance of developing cancer grows up to 8x. Within the US, one in sixty-four people would develop the said form of cancer over their life form. Additionally, around 60,000 people have been diagnosed with pancreatic cancer in 2021-while the mortality rate touches the count of 48,220 people. Which is nearly 80% of the incidental findings. A cross-sectional cohort study even related that a blockage of the main pancreatic duct caused by cancer can lead to the potential development of chronic pancreatitis. Further, around 495,773 patients were diagnosed around the globe in 2020 who have had been suffering from pancreatitis cancer. Furthermore, the condition can also be caused by drinking a higher amount of alcohol over a long period of time. As per NIAAA, around 85.6% of people above the age of 18 have reported that they have/had drunk alcohol at some of their time. Furthermore, around 6.3% of the people reported that they engaged in heavy alcohol consumption owing to a pandemic or other stress-related factors. Growing urbanizations would rightly reflect in the growing numbers of such cases.

Chronic Pancreatitis Pain Market Challenges

No sentinel line of treatment supplemented by high-cost attributions impedes market growth.

Surgery has been kept as the last resort for pain management, provided that conservative measures and endoscopy treatments have failed. Surgical procedures in chronic pancreatitis involve pancreatic parenchymal resection, pancreatic duct drainage, or a combination of both. Studies after studies have indicated that early surgical treatment is far superior to other forms of treatment. High-cost implications have been seen as well, and the soaring cost is in no way going to stop. Studies and analyses of various theoretical papers suggest that around $614 can be spent on pain medication, while $1,761 has been the annual cost for diabetic medication. Additionally, around $4,114 has been the per-patient cost for pancreatic enzyme replacement therapy. Further, the cost associated with each regular surgery, which also included hospital stays rounded up to $42,951. Owing to such factors, the market’s growth is impeded. Medical insurance coverage plans have been soaring owing to the rising claims owing to COVID-19, which would be a large deterrent for the market.

Chronic Pancreatitis Pain Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Chronic Pancreatitis Pain Market. The top-10 Chronic Pancreatitis Pain Market key companies are-

  1. Abbott Laboratories
  2. Aptalis Pharma, Inc.
  3. McNeil Consumer Healthcare
  4. Oxykem, Lonmin
  5. Sun Biopharma
  6. Radboud University
  7. University Medicine Greifswald
  8. University of Albama
  9. MUSC Health
  10. Mayo Healthcare

Recent Developments

  • In January 2022, Cold Spring Harbor Laboratory, U.S., commenced their study to understand the right treatment path for cystic fibrosis, a primary concern leading to chronic pancreatic. Further, new clinical studies have shed a positive understanding of treatment plans. Researchers developed a cocktail of two antisense oligonucleotides (ASOs) that promotes the skipping of exon 23 of the CFTR-W1282X mRNA. The resulting mRNA is NMD resistant and preserves the reading frame. Its translation produces CFTR-ex23 protein that improves CFTR activity in human bronchial epithelial cells. The acquired results set the stage for developing an ASO therapy for CF caused by the W1282X mutation.
  • In November 2021, AIIMS New Delhi, India conducted trials, results from which demonstrated a new case series indicating, that ultrasound-guided erector spinae plane (ESP) block may prove to be an effective analgesic technique in patients suffering acute on chronic pancreatitis pain. These promising early results may be due to the spread of local anesthetic to the sympathetic nerve roots that form the celiac plexus—particularly via the paravertebral space—making the ESP block a potentially important part of multimodal analgesia in patients.
  • In December 2020, Group of researchers from the Department of Psychology and Collaborative Neuroscience Program, Institute of Drug Research, Medical Facility, Hebrew University, and Department of Psychology and Collaborative Neuroscience Program undertook a study to portray how non-psychoactive cannabinoid cannabidiol (CBD) can be used as an effective remedy for reducing chronic pancreatic pain. 

Relevant Titles

Cold Pain Therapy Market- Forecast (2022-2027
Report Code- HCR 0523

Drug Delivery Market- Forecast (2022-2027)
Report Code- HCR 0064

Analgesics Market-Forecast (2022-2027)
Report Code- HCR 0016

For more Lifesciences and Healthcare related reports, please click here

1. Chronic Pancreatitis Pain Market Overview
    1.1 Definitions and Scope
2. Chronic Pancreatitis Pain Market- Executive Summary
3. Chronic Pancreatitis Pain Market – Market Landscape
    3.1 Company Benchmarking- Key Companies
    3.2 Key Company Financial Analysis
    3.3 Market Share Analysis
    3.4 Patent Analysis
    3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. Chronic Pancreatitis Pain Market – Startup Company Scenario (Premium)
    4.1 Investment
    4.2 Revenue
    4.3 Venture Capital and Funding Scenario
5. Chronic Pancreatitis Pain Market – Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Scenario
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Chronic Pancreatitis Pain Market - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Chronic Pancreatitis Pain Market – By Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle Analysis
8. Chronic Pancreatitis Pain Market- By Causes (Market Size –$Million/$Billion) 
    8.1 Damaged Pancreatic Duct Cancer
    8.2 Auto-Immune Disease
    8.3 Cystic Fibrosis
    8.4 Hereditary
    8.5 Others
9. Chronic Pancreatitis Pain Market- By Diagnosis (Market Size –$Million/$Billion) 
    9.1 Blood Tests
    9.2 Imaging Techniques
    9.3 Endoscopy
    9.4 Others
10. Chronic Pancreatitis Pain Market- By Treatment (Market Size –$Million/$Billion) 
    10.1 Lifestyle Management (Conservative Management)
    10.2 Endoscopy Treatments
    10.3 Surgical Interventions
11.  Chronic Pancreatitis Pain Market - By Geography (Market Size -$Million/Billion)
    11.1 North America
        11.1.1 U.S
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 Germany
        11.2.2 France
        11.2.3 UK
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 Japan
        11.3.3 South Korea
        11.3.4 India
        11.3.5 Australia & New Zealand
        11.3.6 Rest of APAC
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Chile
        11.4.4 Colombia
        11.4.5 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Chronic Pancreatitis Pain Market - Market Entropy
    12.1 New product launches
    12.2 M&A's, collaborations, JVs and partnerships
13. Chronic Pancreatitis Pain Market – Industry Competition Landscape (Premium)
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key Companies
        13.1.3 Market Share by Countries – Key Companies
    13.2 Competition Matrix
    13.3 Best Practices for Companies
14. Chronic Pancreatitis Pain Market – Key Company List by Country Premium (Premium)
15. Chronic Pancreatitis Pain Market - Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials would be provided on a best-efforts basis for private companies
List of Tables

Table 1 Chronic Pancreatitis Pain Market Overview 2021-2026
Table 2 Chronic Pancreatitis Pain Market Leader Analysis 2018-2019 (US$)
Table 3 Chronic Pancreatitis Pain Market Product Analysis 2018-2019 (US$)
Table 4 Chronic Pancreatitis Pain Market End User Analysis 2018-2019 (US$)
Table 5 Chronic Pancreatitis Pain Market Patent Analysis 2013-2018* (US$)
Table 6 Chronic Pancreatitis Pain Market Financial Analysis 2018-2019 (US$)
Table 7 Chronic Pancreatitis Pain Market Driver Analysis 2018-2019 (US$)
Table 8 Chronic Pancreatitis Pain Market Challenges Analysis 2018-2019 (US$)
Table 9 Chronic Pancreatitis Pain Market Constraint Analysis 2018-2019 (US$)
Table 10 Chronic Pancreatitis Pain Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11 Chronic Pancreatitis Pain Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12 Chronic Pancreatitis Pain Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13 Chronic Pancreatitis Pain Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14 Chronic Pancreatitis Pain Market Degree of Competition Analysis 2018-2019 (US$)
Table 15 Chronic Pancreatitis Pain Market Value Chain Analysis 2018-2019 (US$)
Table 16 Chronic Pancreatitis Pain Market Pricing Analysis 2021-2026 (US$)
Table 17 Chronic Pancreatitis Pain Market Opportunities Analysis 2021-2026 (US$)
Table 18 Chronic Pancreatitis Pain Market Product Life Cycle Analysis 2021-2026 (US$)
Table 19 Chronic Pancreatitis Pain Market Supplier Analysis 2018-2019 (US$)
Table 20 Chronic Pancreatitis Pain Market Distributor Analysis 2018-2019 (US$)
Table 21 Chronic Pancreatitis Pain Market Trend Analysis 2018-2019 (US$)
Table 22 Chronic Pancreatitis Pain Market Size 2018 (US$)
Table 23 Chronic Pancreatitis Pain Market Forecast Analysis 2021-2026 (US$)
Table 24 Chronic Pancreatitis Pain Market Sales Forecast Analysis 2021-2026 (Units)
Table 25 Chronic Pancreatitis Pain Market, Revenue & Volume,By Application, 2021-2026 ($)
Table 26 Chronic Pancreatitis Pain Market By Application, Revenue & Volume,By Metallurgy, 2021-2026 ($)
Table 27 Chronic Pancreatitis Pain Market By Application, Revenue & Volume,By Dye & Pigments, 2021-2026 ($)
Table 28 Chronic Pancreatitis Pain Market By Application, Revenue & Volume,By Wood Preservatives, 2021-2026 ($)
Table 29 Chronic Pancreatitis Pain Market By Application, Revenue & Volume,By Tanning, 2021-2026 ($)
Table 30 Chronic Pancreatitis Pain Market By Application, Revenue & Volume,By Refractory Material, 2021-2026 ($)
Table 31 Chronic Pancreatitis Pain Market, Revenue & Volume,By Compounds, 2021-2026 ($)
Table 32 Chronic Pancreatitis Pain Market By Compounds, Revenue & Volume,By Chromium (0), 2021-2026 ($)
Table 33 Chronic Pancreatitis Pain Market By Compounds, Revenue & Volume,By Chromium (I), 2021-2026 ($)
Table 34 Chronic Pancreatitis Pain Market By Compounds, Revenue & Volume,By Chromium (II), 2021-2026 ($)
Table 35 Chronic Pancreatitis Pain Market By Compounds, Revenue & Volume,By Chromium (III), 2021-2026 ($)
Table 36 Chronic Pancreatitis Pain Market By Compounds, Revenue & Volume,By Chromium (VI), 2021-2026 ($)
Table 37 North America Chronic Pancreatitis Pain Market, Revenue & Volume,By Application, 2021-2026 ($)
Table 38 North America Chronic Pancreatitis Pain Market, Revenue & Volume,By Compounds, 2021-2026 ($)
Table 39 South america Chronic Pancreatitis Pain Market, Revenue & Volume,By Application, 2021-2026 ($)
Table 40 South america Chronic Pancreatitis Pain Market, Revenue & Volume,By Compounds, 2021-2026 ($)
Table 41 Europe Chronic Pancreatitis Pain Market, Revenue & Volume,By Application, 2021-2026 ($)
Table 42 Europe Chronic Pancreatitis Pain Market, Revenue & Volume,By Compounds, 2021-2026 ($)
Table 43 APAC Chronic Pancreatitis Pain Market, Revenue & Volume,By Application, 2021-2026 ($)
Table 44 APAC Chronic Pancreatitis Pain Market, Revenue & Volume,By Compounds, 2021-2026 ($)
Table 45 Middle East & Africa Chronic Pancreatitis Pain Market, Revenue & Volume,By Application, 2021-2026 ($)
Table 46 Middle East & Africa Chronic Pancreatitis Pain Market, Revenue & Volume,By Compounds, 2021-2026 ($)
Table 47 Russia Chronic Pancreatitis Pain Market, Revenue & Volume,By Application, 2021-2026 ($)
Table 48 Russia Chronic Pancreatitis Pain Market, Revenue & Volume,By Compounds, 2021-2026 ($)
Table 49 Israel Chronic Pancreatitis Pain Market, Revenue & Volume,By Application, 2021-2026 ($)
Table 50 Israel Chronic Pancreatitis Pain Market, Revenue & Volume,By Compounds, 2021-2026 ($)
Table 51 Top Companies 2018 (US$)Chronic Pancreatitis Pain Market, Revenue & Volume
Table 52 Product Launch 2018-2019Chronic Pancreatitis Pain Market, Revenue & Volume
Table 53 Mergers & Acquistions 2018-2019Chronic Pancreatitis Pain Market, Revenue & Volume


List of Figures

Figure 1 Overview of Chronic Pancreatitis Pain Market 2021-2026
Figure 2 Market Share Analysis for Chronic Pancreatitis Pain Market 2018 (US$)
Figure 3 Product Comparison in Chronic Pancreatitis Pain Market 2018-2019 (US$)
Figure 4 End User Profile for Chronic Pancreatitis Pain Market 2018-2019 (US$)
Figure 5 Patent Application and Grant in Chronic Pancreatitis Pain Market 2013-2018* (US$)
Figure 6 Top 5 Companies Financial Analysis in Chronic Pancreatitis Pain Market 2018-2019 (US$)
Figure 7 Market Entry Strategy in Chronic Pancreatitis Pain Market 2018-2019
Figure 8 Ecosystem Analysis in Chronic Pancreatitis Pain Market 2018
Figure 9 Average Selling Price in Chronic Pancreatitis Pain Market 2021-2026
Figure 10 Top Opportunites in Chronic Pancreatitis Pain Market 2018-2019
Figure 11 Market Life Cycle Analysis in Chronic Pancreatitis Pain Market
Figure 12 GlobalBy ApplicationChronic Pancreatitis Pain Market Revenue, 2021-2026 ($)
Figure 13 GlobalBy CompoundsChronic Pancreatitis Pain Market Revenue, 2021-2026 ($)
Figure 14 Global Chronic Pancreatitis Pain Market - By Geography
Figure 15 Global Chronic Pancreatitis Pain Market Value & Volume, By Geography, 2021-2026 ($) 
Figure 16 Global Chronic Pancreatitis Pain Market CAGR, By Geography, 2021-2026 (%)
Figure 17 North America Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 18 US Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 19 US GDP and Population, 2018-2019 ($)
Figure 20 US GDP – Composition of 2018, By Sector of Origin
Figure 21 US Export and Import Value & Volume, 2018-2019 ($)
Figure 22 Canada Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 23 Canada GDP and Population, 2018-2019 ($)
Figure 24 Canada GDP – Composition of 2018, By Sector of Origin
Figure 25 Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26 Mexico Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 27 Mexico GDP and Population, 2018-2019 ($)
Figure 28 Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29 Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30 South America Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 31 Brazil Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 32 Brazil GDP and Population, 2018-2019 ($)
Figure 33 Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34 Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35 Venezuela Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 36 Venezuela GDP and Population, 2018-2019 ($)
Figure 37 Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38 Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39 Argentina Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 40 Argentina GDP and Population, 2018-2019 ($)
Figure 41 Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42 Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43 Ecuador Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 44 Ecuador GDP and Population, 2018-2019 ($)
Figure 45 Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46 Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47 Peru Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 48 Peru GDP and Population, 2018-2019 ($)
Figure 49 Peru GDP – Composition of 2018, By Sector of Origin
Figure 50 Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51 Colombia Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 52 Colombia GDP and Population, 2018-2019 ($)
Figure 53 Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54 Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55 Costa Rica Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 56 Costa Rica GDP and Population, 2018-2019 ($)
Figure 57 Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58 Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59 Europe Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 60 U.K Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 61 U.K GDP and Population, 2018-2019 ($)
Figure 62 U.K GDP – Composition of 2018, By Sector of Origin
Figure 63 U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64 Germany Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 65 Germany GDP and Population, 2018-2019 ($)
Figure 66 Germany GDP – Composition of 2018, By Sector of Origin
Figure 67 Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68 Italy Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 69 Italy GDP and Population, 2018-2019 ($)
Figure 70 Italy GDP – Composition of 2018, By Sector of Origin
Figure 71 Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72 France Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 73 France GDP and Population, 2018-2019 ($)
Figure 74 France GDP – Composition of 2018, By Sector of Origin
Figure 75 France Export and Import Value & Volume, 2018-2019 ($)
Figure 76 Netherlands Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 77 Netherlands GDP and Population, 2018-2019 ($)
Figure 78 Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79 Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80 Belgium Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 81 Belgium GDP and Population, 2018-2019 ($)
Figure 82 Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83 Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84 Spain Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 85 Spain GDP and Population, 2018-2019 ($)
Figure 86 Spain GDP – Composition of 2018, By Sector of Origin
Figure 87 Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88 Denmark Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 89 Denmark GDP and Population, 2018-2019 ($)
Figure 90 Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91 Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92 APAC Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 93 China Chronic Pancreatitis Pain Market Value & Volume, 2021-2026
Figure 94 China GDP and Population, 2018-2019 ($)
Figure 95 China GDP – Composition of 2018, By Sector of Origin
Figure 96 China Export and Import Value & Volume, 2018-2019 ($)Chronic Pancreatitis Pain Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 97 Australia Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 98 Australia GDP and Population, 2018-2019 ($)
Figure 99 Australia GDP – Composition of 2018, By Sector of Origin
Figure 100 Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101 South Korea Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 102 South Korea GDP and Population, 2018-2019 ($)
Figure 103 South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104 South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105 India Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 106 India GDP and Population, 2018-2019 ($)
Figure 107 India GDP – Composition of 2018, By Sector of Origin
Figure 108 India Export and Import Value & Volume, 2018-2019 ($)
Figure 109 Taiwan Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 110 Taiwan GDP and Population, 2018-2019 ($)
Figure 111 Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112 Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113 Malaysia Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 114 Malaysia GDP and Population, 2018-2019 ($)
Figure 115 Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116 Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117 Hong Kong Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 118 Hong Kong GDP and Population, 2018-2019 ($)
Figure 119 Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120 Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121 Middle East & Africa Chronic Pancreatitis Pain Market Middle East & Africa 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 122 Russia Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 123 Russia GDP and Population, 2018-2019 ($)
Figure 124 Russia GDP – Composition of 2018, By Sector of Origin
Figure 125 Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126 Israel Chronic Pancreatitis Pain Market Value & Volume, 2021-2026 ($)
Figure 127 Israel GDP and Population, 2018-2019 ($)
Figure 128 Israel GDP – Composition of 2018, By Sector of Origin
Figure 129 Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130 Entropy Share, By Strategies, 2018-2019* (%)Chronic Pancreatitis Pain Market 
Figure 131 Developments, 2018-2019*Chronic Pancreatitis Pain Market 
Figure 132 Company 1 Chronic Pancreatitis Pain Market Net Revenue, By Years, 2018-2019* ($)
Figure 133 Company 1 Chronic Pancreatitis Pain Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134 Company 1 Chronic Pancreatitis Pain Market Net Sales Share, By Geography, 2018 (%)
Figure 135 Company 2 Chronic Pancreatitis Pain Market Net Revenue, By Years, 2018-2019* ($)
Figure 136 Company 2 Chronic Pancreatitis Pain Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137 Company 2 Chronic Pancreatitis Pain Market Net Sales Share, By Geography, 2018 (%)
Figure 138 Company 3Chronic Pancreatitis Pain Market Net Revenue, By Years, 2018-2019* ($)
Figure 139 Company 3Chronic Pancreatitis Pain Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140 Company 3Chronic Pancreatitis Pain Market Net Sales Share, By Geography, 2018 (%)
Figure 141 Company 4 Chronic Pancreatitis Pain Market Net Revenue, By Years, 2018-2019* ($)
Figure 142 Company 4 Chronic Pancreatitis Pain Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143 Company 4 Chronic Pancreatitis Pain Market Net Sales Share, By Geography, 2018 (%)
Figure 144 Company 5 Chronic Pancreatitis Pain Market Net Revenue, By Years, 2018-2019* ($)
Figure 145 Company 5 Chronic Pancreatitis Pain Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146 Company 5 Chronic Pancreatitis Pain Market Net Sales Share, By Geography, 2018 (%)
Figure 147 Company 6 Chronic Pancreatitis Pain Market Net Revenue, By Years, 2018-2019* ($)
Figure 148 Company 6 Chronic Pancreatitis Pain Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149 Company 6 Chronic Pancreatitis Pain Market Net Sales Share, By Geography, 2018 (%)
Figure 150 Company 7 Chronic Pancreatitis Pain Market Net Revenue, By Years, 2018-2019* ($)
Figure 151 Company 7 Chronic Pancreatitis Pain Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152 Company 7 Chronic Pancreatitis Pain Market Net Sales Share, By Geography, 2018 (%)
Figure 153 Company 8 Chronic Pancreatitis Pain Market Net Revenue, By Years, 2018-2019* ($)
Figure 154 Company 8 Chronic Pancreatitis Pain Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155 Company 8 Chronic Pancreatitis Pain Market Net Sales Share, By Geography, 2018 (%)
Figure 156 Company 9 Chronic Pancreatitis Pain Market Net Revenue, By Years, 2018-2019* ($)
Figure 157 Company 9 Chronic Pancreatitis Pain Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158 Company 9 Chronic Pancreatitis Pain Market Net Sales Share, By Geography, 2018 (%)
Figure 159 Company 10 Chronic Pancreatitis Pain Market Net Revenue, By Years, 2018-2019* ($)
Figure 160 Company 10 Chronic Pancreatitis Pain Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161 Company 10 Chronic Pancreatitis Pain Market Net Sales Share, By Geography, 2018 (%)
Figure 162 Company 11 Chronic Pancreatitis Pain Market Net Revenue, By Years, 2018-2019* ($)
Figure 163 Company 11 Chronic Pancreatitis Pain Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164 Company 11 Chronic Pancreatitis Pain Market Net Sales Share, By Geography, 2018 (%)
Figure 165 Company 12 Chronic Pancreatitis Pain Market Net Revenue, By Years, 2018-2019* ($)
Figure 166 Company 12 Chronic Pancreatitis Pain Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167 Company 12 Chronic Pancreatitis Pain Market Net Sales Share, By Geography, 2018 (%)
Figure 168 Company 13Chronic Pancreatitis Pain Market Net Revenue, By Years, 2018-2019* ($)
Figure 169 Company 13Chronic Pancreatitis Pain Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170 Company 13Chronic Pancreatitis Pain Market Net Sales Share, By Geography, 2018 (%)
Figure 171 Company 14 Chronic Pancreatitis Pain Market Net Revenue, By Years, 2018-2019* ($)
Figure 172 Company 14 Chronic Pancreatitis Pain Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173 Company 14 Chronic Pancreatitis Pain Market Net Sales Share, By Geography, 2018 (%)
Figure 174 Company 15 Chronic Pancreatitis Pain Market Net Revenue, By Years, 2018-2019* ($)
Figure 175 Company 15 Chronic Pancreatitis Pain Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176 Company 15 Chronic Pancreatitis Pain Market Net Sales Share, By Geography, 2018 (%)